Immediate release three-layered chewing gum tablets of fenoprofen calcium: preparation, optimization and bioavailability studies in healthy human volunteers

References

• European Pharmacopoeia 4th edn. (2002). Strasbourg, France: Directorate for the Quality of Medicines of the Council of Europe: Chewing gum, medicated drug release, 227–228.
   Google Scholar
• Abelson DC, Barton J, Mandel ID. (1990). The effect of chewing sorbitol-sweetened gum on salivary flow and cemental plaque pH in subjects with low salivary flow. J Clin Dent, 2:3–5.
   PubMedGoogle Scholar
• Woodford DW, Lesko LJ. (1981). Relative bioavailability of aspirin gum. J Pharm Sci, 70:1341–1343.
   PubMed Web of Science ®Google Scholar
• Bousquet E, Tirendi S, Bonina FP, Montenegro L, Bianchi A, Ciampini N. (1992). Bioavailability of two formulations of acetylsalicylic acid gums. Pharmazie, 47:607–609.
   PubMed Web of Science ®Google Scholar
• Christrup LL, Bonde J, Rasmussen SN, Rassing MR. (1990). Relative bioavailability of (+/-)-verapamil hydrochloride administered in tablets and chewing gum. Acta Pharm Nord, 2:371–376.
   PubMedGoogle Scholar
• Benowitz NL, Jacob P 3rd, Savanapridi C. (1987). Determinants of nicotine intake while chewing nicotine polacrilex gum. Clin Pharmacol Ther, 41:467–473.
   PubMed Web of Science ®Google Scholar
• Davoli E, Stramare L, Fanelli R, Diomede L, Salmona M. (1998). Rapid solid-phase extraction method for automated gas chromatographic-mass spectrometric determination of nicotine in plasma. J Chromatogr B Biomed Sci Appl, 707:312–316.
   PubMed Web of Science ®Google Scholar
• Rassing MR. (1994). Chewing gum as drug delivery system. Adv Drug Deliv Rev, 13:89–121.
   Web of Science ®Google Scholar
• Shargel L, Yu A. (1999). Applied biopharmaceutics and pharmacokinetics. Appleton and Lange, 119–120.
   Google Scholar
• Christrup LL, Angelo HR, Bonde J, Kristensen F, Rasmussen SN. (1990). Relative bioavailability of methadone hydrochloride administered in chewing gum and tablets. Acta Pharm Nord, 2:83–88.
   PubMedGoogle Scholar
• Rindum JL, Holmstrup P, Pedersen M, Rassing MR, Stoltze K. (1993). Miconazole chewing gum for treatment of chronic oral candidosis. Scand J Dent Res, 101:386–390.
   PubMedGoogle Scholar
• Yamini M, William JI, Paul XB, Rick SC, Barbara RC. (2004). In vitro release of nicotine from chewing gum formulations. Dissolution Technol, 11:12–15.
   Google Scholar
• Annette G, Jay WM. (2009). Available at: http://www.rxlist.com. Accessed on 4 April 2009.
   Google Scholar
• Poggi JC, Barissa GR, Donadi EA, Foss MC, de Queiroz Cunha F, Lanchote VL, Reis MLD. (2006). Pharmacodynamics, chiral pharmacokinetics, and pharmacokinetic-pharmacodynamic modeling of fenoprofen in patients with diabetes mellitus. J Clin Pharmacol, 46:1328–1336.
   PubMed Web of Science ®Google Scholar
• Maggi L, Segale L, Conti S, Ochoa Machiste E, Salini A, Conte U. (2005). Preparation and evaluation of release characteristics of 3TabGum, a novel chewing device. Eur J Pharm Sci, 24:487–493.
   PubMed Web of Science ®Google Scholar
• Ochoa E, Maggi L, Conti S, Conte U, Vergnault G, Grenier P. (2008). Use of dye as tracer of drug release from medicated chewing gums. Eur J Pharm Biopharm, 68:811–817.
   PubMed Web of Science ®Google Scholar
• Yang X, Wang G, Zhang X. (2004). Release kinetics of catechins from chewing gum. J Pharm Sci, 93:293–299.
   PubMed Web of Science ®Google Scholar
• Patil A, Pore Y, Kuchekar B. (2008). Effect of L-Arginine on bicalutamide complexation with hydroxypropyl-β-cyclodextrin. Digest J Nanomat & Biostruct, 3:89–98.
   Web of Science ®Google Scholar
• Higuchi T, Connors K. (1965). Phase-solubility techniques. Advances in Analyt Chem Instrum, 4:117–212.
   Google Scholar
• Nalluri BN, Chowdary KP, Murthy KV, Hayman AR, Becket G. (2003). Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systems. AAPS PharmSciTech, 4:E2.
   PubMedGoogle Scholar
• Patel AR, Vavia PR. (2006). Effect of hydrophilic polymer on solubilization of fenofibrate by cyclodextrin complexation. J Inclus Phen & Macrocycl Chem, 56:247–251.
   Web of Science ®Google Scholar
• Celebi N, Erden N. (1992). interaction of naproxen with β-cyclodextrin in ground mixture. Int J Pharm, 78:183–87.
   Web of Science ®Google Scholar
• Palmieri GF, Galli-angeli D, Goiovannucci G, Martelli S. (1997). Inclusion of methoxybutropate in β and hydroxypropyl-β-cyclodextrin: Comparison of preparation methods. Drug Dev Indust Pharm, 23:27–37.
   Web of Science ®Google Scholar
• Kurozumi M, Nambu N, Nagai T. (1975). Inclusion compounds of non-steroidal antiinflammatory and other slightly water soluble drugs with α- and β-cyclodextrins in powdered form. Chem Pharm Bull, 23:3062–3068.
   PubMed Web of Science ®Google Scholar
• Ventura CA, Pulglisi G, Giammona G, Bottino FA. (1994). Comparative study on inclusion compounds of 4-biphenylacetic acid with β-cyclodextrin, Hydroxypropylated-β-cyclodextrins and methylated β-cyclodextrins. Drug Dev Ind Pharm, 20:2245–2265.
   Web of Science ®Google Scholar
• Bhargava S, Agrawal GP. (2008). Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with β-cyclodextrin. Curr Drug Deliv, 5:1–6.
   PubMedGoogle Scholar
• Patterson J, Bary A, Rades T. (2002). Physical stability and solubility of the thermotropic mesophase of fenoprofen calcium as pure drug and in a tablet formulation. Int J Pharm, 247:147–157.
   PubMedGoogle Scholar
• SPI Pharma Group (2003). Directly compressible chewing gum delivery system. Technical Bulletin.
   Google Scholar
• European Pharmacopoeia 4th ed. (2002) Strasbourg, France: Directorate for the Quality of Medicines of the Council of Europe: Dosage Forms, p. 537.
   Google Scholar
• Ellermann Carecom 2nd ed. (2003): Development of medical chewing gum.
   Google Scholar
• Charnay C, Lagerge S, Partyka S. (2000). Determination of surface heterogeneity of talc materials. Prog Colloid Polym Sci, 115:66–71
   Google Scholar
• Kuno Y, Kojima M, Nakagami H, Yonemochi E, Terada K. (2008). Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol. Eur J Pharm Biopharm, 69:986–992.
   PubMed Web of Science ®Google Scholar
• Terada K, Yonemochi E. (2004). Physicochemical properties and surfacefree energy of ground talc. Solid State Ionics, 172:459–462.
   Web of Science ®Google Scholar
• Albertini B, Passerini N, González-Rodríguez ML, Perissutti B, Rodriguez L. (2004). Effect of Aerosil on the properties of lipid controlled release microparticles. J Control Release, 100:233–246.
   PubMed Web of Science ®Google Scholar
• Khan S, Kataria P, Nakhat P, Yeole P. (2007). Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets. AAPS PharmSciTech, 8:Article 46.
   Web of Science ®Google Scholar
• Ribeiro L, Carvalho RA, Ferreira DC, Veiga FJ. (2005). Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies. Eur J Pharm Sci, 24:1–13.
   PubMed Web of Science ®Google Scholar
• Racz I. (1989). Drug Formulation John Wiley and sons: Budapest.
   Google Scholar
• Lin SY, Kao YH. (1989). Solid particles of drug-β-cyclodextrin inclusion complexes directly prepared by a spray-drying technique. Int J Pharm, 56:249–259.
   Google Scholar
• Esclusa-Diaz MT, Guimaraenes-Mendez M, Perez-Macros MB, Vila-Jato JL, Torres-Labandeira JJ. (1996). Characterization and in vitro dissolution of ketoconazole-β-cyclodextrin and 2-hydroxypropyl-β-cyclodextin inclusion compounds. Int J Pharm, 143:203–210.
   Google Scholar
• Betageri GV, Makarla KR. (1995). Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques. Int J Pharm, 126:155–160.
   Web of Science ®Google Scholar
• Dhanaraju MD, Kumaran KS, Baskaran T, Moorthy MS. (1998). Enhancement of bioavailability of griseofulvin by its complexation with β-cyclodextrin. Drug Dev Ind Pharm, 24:583–587.
   PubMed Web of Science ®Google Scholar
• Becket G, Schep LJ, Tan MY. (1999). Improvement of the in vitro dissolution of praziquantel by complexation with α-, β and γ-cyclodextrins. Int J Pharm, 179:65–71.
   PubMed Web of Science ®Google Scholar
• Ribeiro LS, Ferreira DC, Veiga FJ. (2003). Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with β-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. Eur J Pharm Sci, 20:253–266.
   PubMed Web of Science ®Google Scholar
• Veiga F, Teixeira-Dias JJC, Kedzierewicz F, Sousa A, Maincent P. (1996). Inclusion complexation of tolbutamide with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. Int J Pharm, 129:63–71.
   Web of Science ®Google Scholar
• Zhu H, Xu J, Varlashkin P, Long S, Kidd C. (2001). Dehydration, hydration behavior, and structural analysis of fenoprofen calcium. J Pharm Sci, 90:845–859.
   PubMed Web of Science ®Google Scholar
• Ahmed MO, El-Gibaly I, Ahmed SM. (1998). Effect of cyclodextrins on the physico-chemical properties and antimycotic activity of clotrimazole. Int J Pharm, 171:111–121.
   Web of Science ®Google Scholar
• Montassier P, Duchene D, Poelman MC. (1997). Inclusion complexes of treintoin with cyclodextrins. Int J Pharm, 153:199–209.
   Web of Science ®Google Scholar
• Boudad H, Legrand P, Lebas G, Cheron M, Duchêne D, Ponchel G. (2001). Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir. Int J Pharm, 218:113–124.
   PubMed Web of Science ®Google Scholar
• Jacobsen J, Christrup L, Jensen N. (2004). Medicated chewing gum: Pros and cons. Am J Drug Deliv, 2:75–88.
   Google Scholar